{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T13:55:42Z","timestamp":1788184542073,"version":"build-2803163510"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1097\/mjt.0b013e3181cea0b3","type":"journal-article","created":{"date-parts":[[2010,3,24]],"date-time":"2010-03-24T04:15:25Z","timestamp":1269404125000},"page":"e167-e171","source":"Crossref","is-referenced-by-count":7,"title":["Docetaxel-Induced Thrombotic Thrombocytopenic Purpura\/Hemolytic Uremic Syndrome\u2013Related Complex in a Patient With Metastatic Prostate Cancer?"],"prefix":"10.1097","volume":"18","author":[{"given":"Anuj","family":"Shrestha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pam","family":"Khosla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20-20210202","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1055\/s-2005-925474","article-title":"Drug-induced thrombotic microangiopathy.","volume":"31","author":"Zakarija","year":"2005","journal-title":"Semin Thromb Hemost"},{"key":"R2-20-20210202","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1634\/theoncologist.8-4-375","article-title":"Thrombotic thrombocytopenic purpura associated with bone marrow metastasis and secondary myelofibrosis in cancer.","volume":"8","author":"Chang","year":"2003","journal-title":"Oncologist"},{"key":"R3-20-20210202","doi-asserted-by":"crossref","first-page":"211","DOI":"10.4143\/crt.2008.40.4.211","article-title":"TTP-HUS associated with sunitinib.","volume":"40","author":"Choi","year":"2008","journal-title":"Cancer Res Treat"},{"key":"R4-20-20210202","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.4065\/76.11.1154","article-title":"Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome, concise review for clinicians.","volume":"76","author":"Elliott","year":"2001","journal-title":"Mayo Clin Proc"},{"key":"R5-20-20210202","first-page":"121","article-title":"TTP and ADAMTS13: when is testing appropriatehematology\/the Education Program of the American Society of Hematology, American Society of Hematology.","volume":"2007","author":"Mannucci","year":"2007","journal-title":"Educ Program"},{"key":"R6-20-20210202","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.2146\/ajhp070432","article-title":"Paclitaxel-induced sickle cell crisis.","volume":"65","author":"Wilson","year":"2008","journal-title":"Am J Health Syst Pharmacy"},{"key":"R7-20-20210202","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1055\/s-2007-1000365","article-title":"Reduced von Willebrand factor-cleaving protease levels in secondary thrombotic microangiopathies and other diseases.","volume":"33","author":"Franchini","year":"2007","journal-title":"Semin Thromb Hemost"},{"key":"R8-20-20210202","first-page":"405","article-title":"Singer, K, Singer, L, Goldberg, SR. Studies on abnormal hemoglobins. XI. Sickle cell thalassemia disease in the negro. The significance of the S+A+F and S+A patterns obtained by hemoglobin analysis.","volume":"10","year":"1955","journal-title":"Blood"},{"key":"R9-20-20210202","first-page":"289","article-title":"Clinical features of the genetic variants of sickle cell disease.","volume":"94","author":"Smith","year":"1954","journal-title":"Bull Johns Hopk Hosp"},{"key":"R10-20-20210202","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1365-2141.1991.tb08589.x","article-title":"A comparison of sickle cell syndromes in northern Greece.","volume":"77","author":"Christakis","year":"1991","journal-title":"Br J Haematol"},{"key":"R11-20-20210202","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-2141.1979.tb03684.x","article-title":"Serjeant, GR, Sommereux, AM, Stevenson M, et al. Comparison of sickle cell-beta0 thalassaemia with homozygous sickle cell disease.","volume":"41","year":"1979","journal-title":"Br J Haematol"},{"key":"R12-20-20210202","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0002-9343(01)00835-X","article-title":"Exercise-induced myocardial perfusion abnormalities in sickle beta-thalassemia: Tc-99m tetrofosmin gated SPECT imaging study.","volume":"111","author":"Aessopos","year":"2001","journal-title":"Am J Med"},{"key":"R13-20-20210202","first-page":"288","article-title":"Cerebrovascular accidents in sickle cell disease: rates and risk factors.","volume":"91","author":"Ohene-Frempong","year":"1998","journal-title":"Blood"},{"key":"R14-20-20210202","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJM199107043250103","article-title":"Pain in sickle cell disease: rates and risk factors.","volume":"325","author":"Platt","year":"1991","journal-title":"N Engl J Med"},{"key":"R15-20-20210202","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1182\/blood-2002-05-1397","article-title":"Cloning, expression, and functional characterization of the von Willebrand factor cleaving protease (ADAMTS13).","volume":"100","author":"Plaimauer","year":"2002","journal-title":"Blood"},{"key":"R16-20-20210202","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/(SICI)1096-8652(199804)57:4<293::AID-AJH5>3.0.CO;2-P","article-title":"Increased von Willebrand factor binding to platelets in single episode and recurrent types of thrombotic thrombocytopenic purpura.","volume":"57","author":"Chow","year":"1998","journal-title":"Am J Hematol"},{"key":"R17-20-20210202","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/ki.1987.206","article-title":"HUS and TTP: variable expression of a single entity.","volume":"32","author":"Remuzzi","year":"1987","journal-title":"Kidney Int"},{"key":"R18-20-20210202","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s00277-004-0938-8","article-title":"Hemolytic uremic syndrome following prolonged gemcitabine therapy: report of four cases from a single institution.","volume":"84","author":"Muller","year":"2005","journal-title":"Ann Hematol"},{"key":"R19-20-20210202","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1002\/(SICI)1097-0142(19990501)85:9%3C2023::AID-CNCR21%3E3.0.CO;2-2","article-title":"A review of hemolytic uremic syndrome in patients treated with gemcitabine therapy.","volume":"85","author":"Fung","year":"1999","journal-title":"Cancer"},{"key":"R20-20-20210202","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1002\/cncr.20290","article-title":"Gemcitabine associated thrombotic microangiopathy.","volume":"100","author":"Humphreys","year":"2004","journal-title":"Cancer"},{"key":"R21-20-20210202","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s12032-009-9333-6","article-title":"Thrombotic microangiopathy following docetaxel and trastuzumab chemotherapy: a case report.","volume":"27","author":"Siau","year":"2010","journal-title":"Med Oncol"}],"container-title":["American Journal of Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MJT.0b013e3181cea0b3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:19:44Z","timestamp":1786040384000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00045391-201109000-00020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/mjt.0b013e3181cea0b3","relation":{},"ISSN":["1075-2765"],"issn-type":[{"value":"1075-2765","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}